Wang, Ning |
NCT05092841: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A |
|
|
| Completed | 3 | 176 | RoW | PXT3003, (RS)-baclofen, naltrexone hydrochloride and D-sorbitol oral fixed dose combination, PXT3003 placebo, liquid oral solution | Tasly GeneNet Pharmaceuticals Co., Ltd | Charcot-Marie-Tooth Type 1A | 03/24 | 03/24 | | |
| Recruiting | 3 | 248 | RoW | pimavanserin tartrate, placebo | Tasly Pharmaceutical Group Co., Ltd | Parkinson's Disease Psychosis | 06/25 | 01/26 | | |
NCT06546397: Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion |
|
|
| Recruiting | 1 | 200 | RoW | 17β-estradiol/dydrogesterone tablets | Women's Hospital School Of Medicine Zhejiang University | Pregnancy Complications | 09/25 | 12/25 | | |
NCT06231264: Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis |
|
|
| Recruiting | N/A | 96 | RoW | transcutaneous electrical acustimulation at treatment sites, TEA, transcutaneous electrical acustimulation at sham sites, sham-TEA | Xijing Hospital | Ulcerative Colitis | 01/25 | 03/25 | | |
NCT04303962: Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome |
|
|
| Recruiting | N/A | 200 | RoW | | Ning Wang, MD., PhD. | Guillain-barre Syndrome | 01/24 | 01/25 | | |
| Recruiting | N/A | 200 | RoW | antibiotic-impregnated catheter | Integra LifeSciences Corporation | Hydrocephalus | 07/26 | 12/26 | | |
NCT04008329: A Registered Cohort Study on Amyotrophic Lateral Sclerosis |
|
|
| Recruiting | N/A | 2000 | RoW | | First Affiliated Hospital of Fujian Medical University | Amyotrophic Lateral Sclerosis | 07/29 | 07/59 | | |
NCT04010201: A Registered Cohort Study on Brain Calcification |
|
|
| Recruiting | N/A | 2000 | RoW | | Wan-Jin Chen, Taipei Veterans General Hospital, Taiwan, Chang Gung Memorial Hospital | Brain Calcification | 12/29 | 12/79 | | |
NCT04006418: A Registered Cohort Study on Spastic Paraplegia |
|
|
| Recruiting | N/A | 500 | RoW | | Wan-Jin Chen | Spastic Paraplegia | 12/39 | 12/49 | | |
NCT04010188: A Registered Cohort Study on Charcot-Marie-Tooth Disease |
|
|
| Recruiting | N/A | 500 | RoW | | Ning Wang, MD., PhD. | Charcot-Marie-Tooth Disease | 12/39 | 12/49 | | |
| Recruiting | N/A | 2000 | RoW | | Wan-Jin Chen | Spinal Muscular Atrophy | 12/39 | 12/49 | | |
NCT04012671: A Registered Cohort Study on Duchenne Muscular Dystrophy |
|
|
| Recruiting | N/A | 2000 | RoW | | Ning Wang, MD., PhD. | Duchenne Muscular Dystrophy | 12/39 | 12/49 | | |
Wang, Guisheng |
NCT05440435: Application of Mobile DR in the Diagnosis of Bone Trauma in High Cold Environment |
|
|
| Recruiting | N/A | 2000 | RoW | digital radiography (DR) | Rongrong Hua | Bone Injury, Artificial Intelligence | 10/22 | 12/22 | | |
Ji, Xunming |
NCT05965687: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3) |
|
|
| Recruiting | 3 | 1230 | RoW | Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA) | Ji Xunming,MD,PhD, Beijing Friendship Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Tongren Hospital, People's Hospital of Beijing Daxing District, Tianjin Huanhu Hospital, Guizhou Provincial People's Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Jining First People's Hospital, Linyi People's Hospital, Nanyang Central Hospital, Rizhao People's Hospital, Zhumadian Central Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, The Second Hospital of Anhui Medical University, Changsha Central Hospital, Jiujiang University Affiliated Hospital, Liaocheng People's Hospital, Chengde Central Hospital, The First Affiliated Hospital of Anhui Medical University, Jiangxi Provincial People's Hopital | Acute Ischemic Stroke | 08/24 | 10/24 | | |
RECAST-MT, NCT06559241: Remote Ischemic Conditioning for Acute Ischemic Stroke Treated with Mechanical Thrombectomy() |
|
|
| Recruiting | 3 | 2105 | RoW | 14-day remote ischemic conditioning, 14-day RIC, 30-day remote ischemic conditioning, 30-day RIC, Endovascular thrombectomy, EVT, Best medical management | Capital Medical University | Acute Ischemic Stroke, Anterior Circulation Brain Infarction | 11/26 | 02/27 | | |
NCT05965193: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L) |
|
|
| Recruiting | 3 | 1230 | RoW | Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA) | Ji Xunming,MD,PhD, Beijing Friendship Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Tongren Hospital, People's Hospital of Beijing Daxing District, Tianjin Huanhu Hospital, Guizhou Provincial People's Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Jining First People's Hospital, Linyi People's Hospital, Nanyang Central Hospital, Rizhao People's Hospital, Zhumadian Central Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, The Second Hospital of Anhui Medical University, Changsha Central Hospital | Acute Ischemic Stroke | 08/25 | 10/25 | | |
| Recruiting | 2/3 | 98 | RoW | Statin | Capital Medical University | Intracerebral Hemorrhage, Statins | 06/24 | 11/24 | | |
IRIS, NCT06238024: Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment |
|
|
| Completed | 2/3 | 108 | RoW | Tocilizumab, NaCl 0.9% 100ml | Suzhou Municipal Hospital of Anhui Province, Xuanwu Hospital, Beijing | Interleukin-6, Ischemic Stroke, Endovascular Treatment | 06/24 | 09/24 | | |
| Recruiting | 2 | 100 | RoW | NBO | Capital Medical University | Acute Stroke, Ischemic Stroke, Acute | 07/22 | 10/22 | | |
| Completed | 2 | 282 | RoW | Normobaric Hyperoxia, NBO, Sham Normobaric Hyperoxia, Sham NBO, Endovascular Thrombectomy, EVT | Capital Medical University, Tianjin Huanhu Hospital, Shengli Oilfield Hospital, Beijing Fengtai You'anmen Hospital, Jiujiang University Affiliated Hospital, Zhangzhou Municipal Hospital of Fujian Province, Baotou Central Hospital, Luoyang Central Hospital, Nanyang Central Hospital, Qingdao Central Hospital, The Third People's Hospital of Jinan, Rizhao People's Hospital, Anyang People's Hospital, Shanghai 10th People's Hospital, Dalian Municipal Central Hospital, Zhoukou Central Hospital, Nanshi Hospital of Nanyang, The second Nanning People's Hospital, Zhumadian Central Hospital, Taizhou Hospital, Second Affiliated Hospital of Nanchang University | Stroke, Acute, Neuroprotection | 05/23 | 05/23 | | |
| Recruiting | 1 | 32 | RoW | chlorpromazine and promethazine, C+P, lytic cocktail, Placebo group, Control group, endovascular thrombectomy, rt-PA, Intravenous thrombolysis | Capital Medical University, Linyi People's Hospital | Acute Ischemic Stroke | 01/25 | 02/25 | | |
RE-HIBER, NCT04554797: Regional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 60 | RoW | Regional Hypothermia | Capital Medical University | Stroke, Neuroprotection, Hypothermia | 12/20 | 03/21 | | |
RIC-PMD, NCT03546309: Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy |
|
|
| Recruiting | N/A | 42 | RoW | RIC group, Medication group | Capital Medical University, The Fifth Medical Center of the Chinese People's Liberation Army (PLA) General Hospital | Moyamoya Disease, Pediatric | 12/24 | 02/25 | | |
| Not yet recruiting | N/A | 40 | NA | remote ischemic conditioning | Capital Medical University | 2,3-Bisphosphoglycerate | 03/21 | 03/21 | | |
NCT02737189: Basilar Artery Occlusion Chinese Endovascular Trial |
|
|
| Completed | N/A | 217 | RoW | Mechanical embolectomy, Medical Treatment | Xuanwu Hospital, Beijing, Zhangzhou Municipal Hospital of Fujian Province, The First People's Hospital of Changzhou, Xinqiao Hospital of Chongqing, Changhai Hospital, Baotou Central Hospital, The 904 Hospital of PLA, Linyi People's Hospital, The 985 Hospital of PLA, Taiyuan, Shanxi, The First Affiliated Hospital with Nanjing Medical University, Tianjin TEDA Hospital, Liaocheng People's Hospital, Luoyang Central Hospital, Subei People's Hospital of Jiangsu Province, PLA 148 Hospital, Zibo, Shandong, Hebei General Hospital, Shengli Oilfield Hospital, Shenzhen Bao'an District People's Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Peking University Binhai Hospital, Beijing Tiantan Hospital, The Military General Hospital of Beijing, PLA, The First Affiliated Hospital of Shanxi Medical University, Beijing Luhe Hospital, Affiliated Hospital of Nantong University, The Affiliated Hospital Of Guizhou Medical University, Nanning Second People's Hospital, Chongqing Three Gorges Central Hospital, The First Affiliated Hospital of Dalian Medical University, The Fifth Central Hospital of Tianjin,TianJin, Yantaishan Hospital, Nanyang Central Hospital, Second Affiliated Hospital of Soochow University, Tianjin Huanhu Hospital, The Affiliated Hospital of Northwest University, Xi'an NO.3 Hospital | Basilar Artery Occlusion, Ischemic Stroke, Cerebrovascular Disorders | 09/21 | 06/22 | | |
| Recruiting | N/A | 60 | RoW | Automatic ischemic conditioning treatment instrument, Regular treatment | Capital Medical University | Cerebral Small Vessel Diseases | 12/21 | 12/21 | | |
NCT05207475: Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA) |
|
|
| Recruiting | N/A | 30 | RoW | Remote ischemic conditioning | Capital Medical University | Cerebral Amyloid Angiopathy | 01/22 | 01/22 | | |
RIC-CAAH, NCT04757597: Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage |
|
|
| Recruiting | N/A | 30 | RoW | Remote ischemic conditioning | Capital Medical University, Wangjing Hospital, China Academy of Chinese Medical Sciences, Bejing Fengtai You'anmen Hospital | Intracerebral Hemorrhage Lobar, Cerebral Amyloid Angiopathy | 03/22 | 06/22 | | |
NCT04470492: Study on Prevention and Treatment of Atherosclerotic Cerebral Occlusive Disease With Remote Ischemic Conditioning |
|
|
| Not yet recruiting | N/A | 700 | NA | Doctormate®+Medical Management, Medical Management | Ji Xunming,MD,PhD | Cerebral Atherosclerosis | 08/22 | 12/22 | | |
NCT05291585: The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis. |
|
|
| Completed | N/A | 60 | RoW | the dedicated venous sinus thrombectomy stent, balloon catheter thrombectomy | Ji Xunming,MD,PhD | Cerebral Venous Sinus Thrombosis | 03/23 | 07/23 | | |
NCT05263531: Remote Ischemic Conditioning for Motor Recovery After Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 20 | RoW | remote ischemic conditioning | Ji Xunming,MD,PhD | Ischemic Stroke | 12/22 | 01/23 | | |
NCT05426707: Remote Ischemic Conditioning for the Treatment of Resistant Hypertension |
|
|
| Not yet recruiting | N/A | 40 | NA | RIC, Sham-RIC | Ji Xunming,MD,PhD | Resistant Hypertension | 02/23 | 03/23 | | |
| Recruiting | N/A | 1000 | RoW | the level of biomarker in bood | Ji Xunming,MD,PhD | Ischemic Stroke | 03/23 | 12/25 | | |
NCT05448248: Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH) |
|
|
| Completed | N/A | 3276 | RoW | | Capital Medical University, Brain Hospital of Hunan Provincial, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Guizhou Provincial People's Hospital | Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis | 12/23 | 12/23 | | |
NCT05342714: Remote Ischemic Conditioning for Chronic Cerebral Artery Occlusion |
|
|
| Recruiting | N/A | 30 | RoW | Remote ischemic conditioning | Capital Medical University | Cerebral Artery Occlusion | 03/23 | 03/23 | | |
NCT05733338: The Effects of Intermittent Hypoxia on Acute Hypoxic Injury |
|
|
| Recruiting | N/A | 100 | RoW | Intermittent Hypoxia, Sham Intermittent Hypoxia | Capital Medical University | Acute Mountain Sickness | 04/23 | 04/23 | | |
NCT05760950: A Cohort Study of Patients With Intracranial Hemorrhage |
|
|
| Recruiting | N/A | 300 | RoW | Routine clinical treatment | Capital Medical University | Intracerebral Hemorrhage | 05/23 | 06/23 | | |
NCT05413837: Anatomical Variation of Cerebral Venous Sinus in Healthy Individuals |
|
|
| Recruiting | N/A | 40 | RoW | anotomy and variation of venous sinus, the level of biomarker in bood | Capital Medical University | Venous Sinus Thrombosis, Cranial | 08/23 | 08/23 | | |
NCT05128422: Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke |
|
|
| Completed | N/A | 120 | RoW | Normobaric oxygen therapy | Capital Medical University | Stroke, Endovascular Treatment, Neuroprotection | 10/23 | 10/23 | | |
| Not yet recruiting | N/A | 136 | RoW | Remote ischemic conditioning (RIC), Sham remote ischemic conditioning (Sham-RIC) | Ji Xunming,MD,PhD | Acute Ischemic Stroke | 12/23 | 12/23 | | |
NCT05820165: Brain Imaging in Cerebral Venous Outflow Disturbance |
|
|
| Recruiting | N/A | 80 | RoW | high-resolution 3D-T1, diffusion tensor imaging (DTI), resting-state functional magnetic resonance imaging (rs-fMRI), arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI), susceptibility-weighted images (SWIs) | Capital Medical University | Abnormal Cerebral Venous Sinus Morphology, Internal Jugular Vein Stenosis, Image | 12/23 | 12/24 | | |
NCT06584318: Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer |
|
|
| Recruiting | N/A | 20 | RoW | Intermittent hypoxia intervention | Capital Medical University | Colorectal Cancer | 03/25 | 04/25 | | |
NBOL, NCT05039697: Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset:Longterm Outcome |
|
|
| Recruiting | N/A | 280 | RoW | oxygen | Capital Medical University | Stroke, Acute, Hypoxia-Ischemia, Brain, ENDOVASCULAR TREATMENT | 04/24 | 04/24 | | |
| Recruiting | N/A | 309 | RoW | Mechanical thrombectomy | Capital Medical University | Acute Ischemic Stroke, Basilar Artery Occlusion | 06/26 | 06/26 | | |
NCT05781880: Normobaric Hyperoxia Stabilizing Ischemic Penumbra |
|
|
| Recruiting | N/A | 78 | RoW | Oxygen 100%, Normobaric hyperoxia | Ji Xunming,MD,PhD | Acute Ischemic Stroke | 11/24 | 12/24 | | |
MIRACLE-S, NCT06688162: Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage--Small Hemorrhage Evacuation |
|
|
| Not yet recruiting | N/A | 750 | NA | Usual Care, Minimally Invasive Soft Channel Brain Haemorrhage Evacuation (scMIS) | Capital Medical University, Fudan University, Linyi People's Hospital | Intracerebral Hemorrhage | 11/26 | 12/26 | | |
MIRACLE-L, NCT06688201: Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation |
|
|
| Recruiting | N/A | 550 | RoW | Other neurosurgical techniques, Minimally Invasive Soft Channel Brain Haemorrhage Evacuation | Capital Medical University, Linyi People's Hospital, Fudan University | Intracerebral Hemorrhage | 11/26 | 12/26 | | |
RICA-2, NCT05982015: Efficacy Study II on Remote Ischemic Conditioning for the Prevention of Stroke-Associated Pneumonia |
|
|
| Completed | N/A | 1651 | RoW | Remote ischemic conditioning, Sham remote ischemic conditioning | Capital Medical University | Stroke | 09/24 | 12/24 | | |
| Not yet recruiting | N/A | 3000 | NA | | Capital Medical University, Beijing Municipal Science & Technology Commission | Cerebral Venous Sinus Thrombosis, Deep Cerebral Vein Thrombosis, Cortical Vein Thrombosis | 05/28 | 05/29 | | |
| Not yet recruiting | N/A | 1000 | RoW | | Capital Medical University | Intracranial Stenosis | 06/22 | 07/22 | | |
| Recruiting | N/A | 500 | RoW | Endovascular Treatment | Capital Medical University | Acute Ischemic Stroke | 12/22 | 06/23 | | |
Wu, Hao |
NCT04667299: Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment |
|
|
| Recruiting | 4 | 270 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Amoxicillin | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 11/21 | 12/21 | | |
| Recruiting | 4 | 732 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Amoxicillin | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 12/22 | | |
NCT05018923: Tetracycline Versus Doxycycline for HP Rescue Therapy |
|
|
| Recruiting | 4 | 242 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Doxycycline, Tetracycline | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 12/22 | | |
NCT05023577: Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients |
|
|
| Recruiting | 4 | 504 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 12/22 | | |
| Recruiting | 4 | 4447 | RoW | Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Doxycycline, Tetracycline | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 06/26 | 06/26 | | |
| Recruiting | 2 | 270 | RoW | TQB2102 for injection, TQB2102 for injection combined with Benmelstobart injection | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Non-Small Cell Lung Cancer | 10/25 | 02/26 | | |
NCT04592315: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients |
|
|
| Completed | 1 | 46 | RoW | Lipovirtide Injection | Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences | HIV Infections | 05/23 | 07/23 | | |
NCT05349968: Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients |
|
|
| Completed | 1 | 24 | RoW | Lipovirtide for injection, nothing | Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences | HIV Infections | 06/23 | 09/23 | | |
NCT05489055: Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA |
|
|
| Recruiting | N/A | 500 | RoW | Iopamidol | Chongqing Emergency Medical Center, Army Medical Center of PLA | Contrast Media Adverse Reaction | 01/23 | 02/23 | | |
| Recruiting | N/A | 96 | RoW | Modified ERAS protocol, routine protocol | Xuanwu Hospital, Beijing | Lumbar Spondylosis, Lumbar Spinal Stenosis, Lumbar Disc Herniation | 08/24 | 04/25 | | |
NCT06029764: Extended One-level Interbody Fusion for Adjacent Vacuum Phenomenon in Lumbar Degenerative Disc Disease |
|
|
| Recruiting | N/A | 126 | RoW | extended one-level interbody fusion | Xuanwu Hospital, Beijing | Adjacent Segment Degeneration | 01/28 | 01/29 | | |
Jia, Jianping |
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease |
|
|
| Recruiting | 4 | 1312 | RoW | GV-971, Placebo | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer's Disease | 06/29 | 12/29 | | |
NCT03789760: The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule |
|
|
| Completed | 3 | 493 | RoW | SaiLuoTong capsule, The effects of SaiLuoTong capsule on VaD, placebo | Shineway Pharmaceutical Co.,Ltd | Vascular Dementia | 03/24 | 05/24 | | |
NCT03804229: Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia |
|
|
| Active, not recruiting | 3 | 707 | RoW | Butylphthalide soft capsule, The effects of Butylphthalide soft capsule on VaD, Placebo soft capsule, Placebo | Capital Medical University, CSPC-NBP Pharmaceutical Co., Ltd. | Vascular Dementia | 10/24 | 02/25 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease |
|
|
| Recruiting | 2a | 60 | RoW | 50561 high dose, 50561 low dose, Placebo | Beijing Joekai Biotechnology LLC | Alzheimer's Disease | 05/24 | 06/24 | | |
NCT05269173: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease |
|
|
| Completed | 2 | 240 | RoW | Flos gossypii flavonoids tablet | Capital Medical University, Xinjiang Uygur Pharmaceutical Co., Ltd. | Alzheimer Disease | 08/24 | 11/24 | | |
NCT05670912: Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease |
|
|
| Terminated | 2 | 105 | RoW | Wei Li Bai capsules, Placebo Comparator of Wei Li Bai capsules | Capital Medical University, China-Japan Friendship Hospital, Beijing Friendship Hospital | Alzheimer Disease | 11/24 | 11/24 | | |
NCT04850053: Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis |
|
|
| Recruiting | N/A | 1500 | RoW | | Capital Medical University, Shandong Provincial Hospital, Xiangya Hospital of Central South University, Zhejiang Provincial People's Hospital, Beijing Geriatric Hospital, Kaifeng Central Hospital, The First Affiliated Hospital of Chongqing Medical Universty, Huashan Hospital, First Affiliated Hospital Xi'an Jiaotong University, West China Hospital, Henan Provincial People's Hospital | Alzheimer's Disease | 12/24 | 12/24 | | |
| Recruiting | N/A | 300 | RoW | Ketogenic diet, placebo | Capital Medical University, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Tianjin Huanhu Hospital, Shandong Provincial Hospital, Peking University Third Hospital, Shanghai Mental Health Center, Beijing Tiantan Hospital, Xiangya Hospital of Central South University, First Affiliated Hospital of Chongqing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Sichuan Provincial People's Hospital, Brain Hospital Affiliated to Guangzhou Medical University, Sir Run Run Shaw Hospital, Zhejiang University | Alzheimer Disease | 05/25 | 05/25 | | |
NCT04575337: Study on Biomarkers for Early Diagnosis of Alzheimer's Disease |
|
|
| Recruiting | N/A | 6000 | RoW | | Capital Medical University | Alzheimer Disease | 06/25 | 06/25 | | |
NCT05020106: The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease |
|
|
| Recruiting | N/A | 3200 | RoW | | Capital Medical University, Shandong Provincial Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Xiangya Hospital of Central South University, Huashan Hospital, The First Hospital of Jilin University | Alzheimer's Disease | 09/25 | 09/25 | | |
| Recruiting | N/A | 100000 | RoW | | Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital | Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia | 01/38 | 01/38 | | |
| Recruiting | N/A | 40000 | RoW | | Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital | Alzheimer Disease, Familial Alzheimer Disease (FAD) | 01/38 | 01/38 | | |
Zhang, Yi |
NCT04771689: Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients |
|
|
| Not yet recruiting | 4 | 60 | US | Buprenorphine/Naloxone, Suboxone | Massachusetts General Hospital | Post-operative Pain | 12/22 | 12/22 | | |
| Recruiting | 4 | 20 | RoW | PCSK9 inhibitor (Alirocumab)plus standard medications, standard medications | Shanghai Tong Ren Hospital | Early PCSK9 Inhibitor on Ventricular Remodling | 12/24 | 06/25 | | |
NCT05292404: Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction |
|
|
| Recruiting | 4 | 160 | RoW | alirocumab, conventional treatment | Shanghai Tong Ren Hospital, China Cardiovascular Association | Acute Myocardial Infarction | 06/25 | 12/25 | | |
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD |
|
|
| Recruiting | 3 | 388 | RoW | HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis | Shanghai Henlius Biotech | Age Related Macular Degeneration | 08/23 | 03/24 | | |
nAMD, NCT05461339: TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | TAB014 Monoclonal Antibody Injection, TAB014, Ranibizumab Injection [Lucentis], Lucentis | TOT Biopharm Co., Ltd., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Neovascular Age-related Macular Degeneration | 09/24 | 02/25 | | |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 3 | 360 | RoW | PM8002, Nab-Paclitaxel, Placebo | Biotheus Inc. | Triple Negative Breast Cancer(TNBC) | 07/27 | 07/28 | | |
NCT06512584: Efficacy and Safety of PJ009 in Patients with Short Bowel Syndrome Requiring Parenteral Nutrition |
|
|
| Recruiting | 3 | 72 | RoW | PJ009, Glucagon-Like Peptide 2 (GLP-2) analogue, PJ009 Placebo, GLP-2 analogue Placebo | Chongqing Peg-Bio Biopharm Co., Ltd. | Short Bowel Syndrome | 03/26 | 04/26 | | |
RC48-C006, NCT03500380: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases |
|
|
| Active, not recruiting | 2/3 | 301 | RoW | RC48-ADC, RC48, Lapatinib, Capecitabine | RemeGen Co., Ltd. | Breast Neoplasms, Breast Diseases, Capecitabine, HER2-positive Breast Cancer, HER2 Positive Breast Carcinoma, HER2-positive Advanced Breast With Liver Metastases | 07/24 | 12/24 | | |
NCT04398940: A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 71 | RoW | TQ-B3139 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 01/22 | 10/22 | | |
NCT06524518: A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive |
|
|
| Not yet recruiting | 2 | 213 | RoW | Chemotherapy combined with immunization | Xuanwu Hospital, Beijing | DFS | 07/26 | 12/29 | | |
NCT03634501: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells |
|
|
| Recruiting | 1/2 | 200 | RoW | Activated NK | Xuanwu Hospital, Beijing | Lung Cancer, Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer | 09/21 | 09/22 | | |
NCT03638206: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies |
|
|
| Recruiting | 1/2 | 73 | RoW | CAR-T cell immunotherapy | Shenzhen BinDeBio Ltd., The First Affiliated Hospital of Zhengzhou University | B-cell Acute Lymphoblastic Leukemia, Lymphoma, Myeloid Leukemia, Multiple Myeloma, Hepatoma, Gastric Cancer, Pancreatic Cancer, Mesothelioma, Colorectal Cancer, Esophagus Cancer, Lung Cancer, Glioma, Melanoma, Synovial Sarcoma, Ovarian Cancer, Renal Carcinoma | 03/23 | 03/23 | | |
NCT05117138: Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors |
|
|
| Not yet recruiting | 1/2 | 39 | RoW | AMT-116 CAR-T cells, AMT-253 CAR-T cells | Beijing Immunochina Medical Science & Technology Co., Ltd. | Melanoma, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | 12/23 | 03/24 | | |
NCT06316791: Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases |
|
|
| Recruiting | 1 | 24 | RoW | single dose of CNCT19 | Juventas Cell Therapy Ltd. | Lupus Erythematosus, Systemic | 12/24 | 12/25 | | |
NCT05122221: CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers |
|
|
| Recruiting | 1 | 12 | RoW | Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01 TCR-T Cell | Corregene Biotechnology Co., Ltd | Cervical Cancer, Anal Cancer, Head and Neck Cancers | 03/23 | 12/24 | | |
NCT06152757: BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors |
|
|
| Recruiting | 1 | 14 | RoW | First dose, Second dose, The third dose, The fourth dose | BioSyngen Pte Ltd, The First Affiliated Hospital of Zhengzhou University | Gastrointestinal Tumors | 07/25 | 07/27 | | |
NCT05381181: Safety and Efficacy Evaluation of Next-generation CD19-UCART |
|
|
| Not yet recruiting | 1 | 20 | NA | CD19-UCART | Bioray Laboratories, The First Affiliated Hospital of Zhengzhou University | Acute Lymphoblastic Leukemia, Non Hodgkin Lymphoma | 05/24 | 05/26 | | |
NCT06077903: GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors |
|
|
| Recruiting | 1 | 20 | RoW | GT101 | Grit Biotechnology | Adult | 07/24 | 07/24 | | |
NCT06515626: Genetically Modified T Cells Treating Malignant Tumors |
|
|
| Recruiting | 1 | 100 | RoW | CAR-T cell reinfusion | Yi Zhang | Solid Tumor | 12/25 | 12/27 | | |
NCT06548620: A Study of RD06-04 in Patients With Active Autoimmune Diseases |
|
|
| Not yet recruiting | 1 | 18 | RoW | RD06-04 cell infusion | Nanjing Bioheng Biotech Co., Ltd. | SLE (Systemic Lupus), Sclerosis, ANCA Associated Vasculitis, IIM, SS, MS, NMO Spectrum Disorder, MG | 08/26 | 08/27 | | |
NCT06671236: Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases |
|
|
| Recruiting | 1 | 12 | US, RoW | Autologous Human Polyclonal Regulatory T Cells Injection (NP001 Cell Injection) | Novabio Therapeutics, The First Affiliated Hospital of Zhengzhou University | Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease(AD), Multiple System Atrophy, MSA | 12/26 | 12/27 | | |
NCT06094426: Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors |
|
|
| Recruiting | 1 | 30 | RoW | GT316 | Grit Biotechnology | Solid Tumor, Adult, GT316 | 02/26 | 02/26 | | |
NCT06560580: Ditefossol Sodium 3% Eye Drops in Patients With Dry Eye |
|
|
| Completed | N/A | 97 | RoW | 3% Diquafosol Sodium Eye Drops | Tianjin Eye Hospital | Dry Eye Disease | 07/23 | 07/24 | | |
NCT05538429: Comparison of Analgesic Effect and Postoperative Recovery of SAPB Combined With ESPB and TPB After Thoracoscopic Surgery |
|
|
| Recruiting | N/A | 92 | RoW | erector spinal plane combined with serratus anterior plane block, thoracic paravertebral block | Zhangyi | Thoracoscopic Surgery, Nerve Block | 10/22 | 11/22 | | |